Published Online: Saturday, April 1, 2006

Reliant Pharmaceuticals Inc has warned pharmacists about recent confusion between its Omacor (omega-3-acid ethyl esters) capsules and Xanodyne Pharmaceuticals Inc's Amicar (aminocaproic acid) tablets. Omacor's manufacturer has informed pharmacists that telephone orders for its drug continue to be "misunderstood and dispensed" as Amicar.

FDA-approved Omacor is indicated as an adjunct to diet for the reduction of very high triglyceride levels. Amicar, however, is indicated for enhancing hemostasis when fibrinolysis contributes to bleeding. In certain patients, Amicar is prescribed for oral use to control acute or chronic bleeding syndromes.

Reliant issued a similar warning in November 2005. The company said that it was developing a "shelf talker" for pharmacists "to help prevent any more medication errors." For more information, visit

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues